Results 261 to 270 of about 188,451 (293)
Some of the next articles are maybe not open access.
[Chronic myelogenous leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013Faramarz Naeim +3 more
+6 more sources
Onconephrology: The intersections between the kidney and cancer
Ca-A Cancer Journal for Clinicians, 2021, Kenar D Jhaveri, Mark A Perazella
exaly
Intermittent fasting in the prevention and treatment of cancer
Ca-A Cancer Journal for Clinicians, 2021Katherine Clifton +2 more
exaly
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Critical reviews in oncology/hematology, 1985
Chronic myelocytic leukemia (CML) is a well-known myeloproliferative disorder, with typical clinical and hematological features, which develops into a lethal blastic crisis within an average of 4 years. In the last few years much has been learned about the cell responsible for the leukemic deviation, chromosomal abnormalities both in chronic phase and ...
openaire +1 more source
Chronic myelocytic leukemia (CML) is a well-known myeloproliferative disorder, with typical clinical and hematological features, which develops into a lethal blastic crisis within an average of 4 years. In the last few years much has been learned about the cell responsible for the leukemic deviation, chromosomal abnormalities both in chronic phase and ...
openaire +1 more source
Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia.
Drug Discovery Today : Technologies, 2014S. Balabanov +2 more
semanticscholar +1 more source
Self-management: Enabling and empowering patients living with cancer as a chronic illness
Ca-A Cancer Journal for Clinicians, 2011Ruth McCorkle +2 more
exaly